RESUMO
BACKGROUND: Plasma cell disorders (PCDs) are typically characterized by excessive production of a single immunoglobulin, defined as a monoclonal protein (M-protein). Some patients have more than one identifiable M-protein, termed biclonal. Traditional immunofixation electrophoresis (IFE) cannot distinguish if two bands of the same isotype represent biclonal proteins or M-proteins with some other feature. A novel assay using immunoenrichment coupled to matrix-assisted laser desorption ionization time-of-flight mass-spectrometry (Mass-Fix) was applied to determine whether two bands of the same isotype represented (1) monomers and dimers of a single M-protein, (2) an M-protein plus a therapeutic monoclonal antibody (t-mAb), (3) an M-protein with light chain glycosylation, or (4) two distinct biclonal M-proteins. METHODS: Patient samples with two bands of the same isotype identified by IFE were enriched using nanobodies against IgG, IgA, IgM, or κ and λ light chains then analyzed by Mass-Fix. Light chain masses were used to differentiate IgGκ M-proteins from t-mAbs. Mass differences between peaks were calculated to identify N-glycosylation or matrix adducts. High-resolution mass spectrometry was used as a comparator method in a subset of samples. RESULTS: Eighty-one residual samples were collected. For IgA, 93% (n = 25) were identified as monoclonal. For IgG, 67% (n = 24) were monoclonal, and 33% (n = 12) were truly biclonal. Among the monoclonal IgGs, the second band represented a glycosylated form for 21% (n = 5), while 33% (n = 8) had masses consistent with a t-mAb. 44% (n = 8) of IgM samples were biclonal, and 56% (n = 10) were monoclonal, of which one was glycosylated. CONCLUSIONS: We demonstrate the utility of mass spectrometry in the characterization of multiple IFE bands of the same isotype. Improved reporting accuracy of M-proteins is useful for monitoring of patients with PCDs.
Assuntos
Anticorpos Monoclonais/sangue , Imunoeletroforese/métodos , Proteínas do Mieloma/análise , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz/métodos , Adulto , Idoso , Idoso de 80 Anos ou mais , Anticorpos Monoclonais/química , Feminino , Humanos , Imunoglobulina G/sangue , Imunoglobulina G/química , Masculino , Pessoa de Meia-Idade , Mieloma Múltiplo/sangue , Proteínas do Mieloma/química , Multimerização Proteica , Espectrometria de Massas por Ionização por ElectrosprayRESUMO
Human immunoglobulin G subclass 3 (IgG3) possesses a uniquely long hinge region that separates its Fab antigen-binding and Fc receptor-binding regions. Owing to this hinge length, the molecular structure of full-length IgG3 remains elusive, and the role of the two conserved Fc glycosylation sites are unknown. To address these issues, we subjected glycosylated and deglycosylated human myeloma IgG3 to multidisciplinary solution structure studies. Using analytical ultracentrifugation, the elongated structure of IgG3 was determined from the reduced sedimentation coefficients s020,w of 5.82 to 6.29 S for both glycosylated and deglycosylated IgG3. X-ray and neutron scattering showed that the Guinier RG values were 6.95 nm for glycosylated IgG3 and were unchanged after deglycosylation, again indicating an elongated structure. The distance distribution function P(r) showed a maximum length of 25 to 28 nm and three distinct maxima. The molecular structure of IgG3 was determined using atomistic modeling based on molecular dynamics simulations of the IgG3 hinge and Monte Carlo simulations to identify physically realistic arrangements of the Fab and Fc regions. This resulted in libraries containing 135,135 and 73,905 glycosylated and deglycosylated IgG3 structures, respectively. Comparisons with the X-ray and neutron scattering curves gave 100 best-fit models for each form of IgG3 that accounted for the experimental scattering curves. These models revealed the first molecular structures for full-length IgG3. The structures exhibited relatively restricted Fab and Fc conformations joined by an extended semirigid hinge, which explains the potent effector functions of IgG3 relative to the other subclasses IgG1, IgG2, and IgG4.
Assuntos
Fragmentos Fab das Imunoglobulinas/química , Imunoglobulina G/química , Mieloma Múltiplo/imunologia , Proteínas do Mieloma/química , Receptores Fc/química , Sequência de Aminoácidos , Cromatografia Líquida/métodos , Glicosilação , Humanos , Espectrometria de Massas/métodos , Simulação de Dinâmica Molecular , Nêutrons , Conformação Proteica , Espalhamento a Baixo Ângulo , Homologia de Sequência de Aminoácidos , Ultracentrifugação/métodos , Difração de Raios XAssuntos
Bilirrubina , Eletroforese das Proteínas Sanguíneas/métodos , Imunoeletroforese/métodos , Mieloma Múltiplo/sangue , Proteínas do Mieloma , Bilirrubina/análise , Bilirrubina/sangue , Feminino , Humanos , Imunoglobulina M/análise , Imunoglobulina M/sangue , Pessoa de Meia-Idade , Proteínas do Mieloma/análise , Proteínas do Mieloma/química , Manejo de Espécimes/métodosAssuntos
Doadores de Sangue , Programas de Rastreamento , Mieloma Múltiplo/diagnóstico , Proteínas do Mieloma/análise , Técnicas de Amplificação de Ácido Nucleico , Segurança do Sangue , Viscosidade Sanguínea , Diagnóstico Precoce , Humanos , Achados Incidentais , Masculino , Pessoa de Meia-Idade , Mieloma Múltiplo/sangue , Proteínas do Mieloma/químicaRESUMO
Monoclonal antibodies are widely used as the capture and detection reagents in diagnostic immunoassays. In the past, myeloma fusion partners expressing endogenous heavy and/or light chains were often used to generate hybridoma cell lines. As a result, mixed populations of antibodies were produced that can cause inaccurate test results, poor antibody stability, and significant lot-to-lot variability. We describe one such scenario where the P3U1 (P3X63Ag8U.1) myeloma fusion partner was used in the generation of a hybridoma producing protein induced vitamin K absence/antagonist-II (PIVKA II) antibody. The hybridoma produces three subpopulations of immunoglobulin as determined by ion exchange (IEx) chromatography that exhibit varying degrees of immunoreactivity (0%, 50%, or 100%) to the target antigen as determined by Surface Plasmon Resonance. To produce an antibody with the highest possible sensitivity and specificity, the antigen-specific heavy and light chain variable domains (VH and VL) were cloned from the hybridoma and tethered to murine IgG1 and kappa scaffolds. The resulting recombinant antibody was expressed in Chinese hamster ovary cells and is compatible for use in a diagnostic immunoassay.
Assuntos
Anticorpos Monoclonais/química , Imunoensaio/normas , Imunoconjugados/química , Imunoglobulina G/química , Cadeias Pesadas de Imunoglobulinas/química , Cadeias Leves de Imunoglobulina/química , Proteínas do Mieloma/química , Sequência de Aminoácidos , Animais , Anticorpos Monoclonais/genética , Biomarcadores , Células CHO , Cricetulus , Expressão Gênica , Humanos , Hibridomas/imunologia , Imunoconjugados/genética , Imunoglobulina G/genética , Cadeias Pesadas de Imunoglobulinas/genética , Cadeias Leves de Imunoglobulina/genética , Camundongos , Mieloma Múltiplo/química , Mieloma Múltiplo/genética , Proteínas do Mieloma/genética , Precursores de Proteínas/genética , Precursores de Proteínas/imunologia , Protrombina/genética , Protrombina/imunologia , Proteínas Recombinantes de Fusão/química , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/imunologia , Sensibilidade e EspecificidadeRESUMO
OBJECTIVE: The roles of serum free light chain ratio (sFLCR) in the diagnosis and prognosis of newly diagnosed multiple myeloma (NDMM) patients were analyzed. METHODS: The clinical data was retrospectively analyzed for 82 newly diagnosed multiple myeloma (NDMM) patients in the first affiliated hospital of Soochow University from September 28, 2012 to July 18, 2105. The serum free light chain levels were measured and κ/λ ratios were calculated, so we could analyze the roles of sFLCR in the diagnosis and prognosis of newly diagnosed multiple myeloma (NDMM) patients. RESULTS: It was 85.5% (70/82) positive of M protein by serum protein electrophoresis (SFE) and 93.9%(77/82) by serum immunofixation electrophoresis (IFE). Both sFLC and sFLCR abnormalities were 96.3% (79/82). The estimated 40-months overall survival was 87% for the high free light chain ratio group (sFLCR ≥100 or≤0.01) and 61% for the low free light chain ratio group (0.01Assuntos
Cadeias Leves de Imunoglobulina/sangue
, Mieloma Múltiplo/diagnóstico
, Células da Medula Óssea
, Humanos
, Hibridização in Situ Fluorescente
, Mieloma Múltiplo/sangue
, Proteínas do Mieloma/química
, Prognóstico
, Insuficiência Renal/complicações
, Estudos Retrospectivos
RESUMO
BACKGROUND: Multiple myeloma and other related monoclonal gammopathies are frequently encountered conditions associated with renal damage, especially in elderly population. They are arising from clonal proliferation of plasma cells in bone marrow producing various quantities of abnormal monoclonal immunoglobulins, or their components/fragments. SUMMARY: These abnormal proteins differ from normal immunoglobulins in the amino acid sequence and in the three-dimensional structure of the molecule, which may determine their toxicity. Kidney seems to be a target organ as a major catabolic site. The pathology of renal disease is highly heterogeneous involving a variety of different mechanisms, which are divided into immunoglobulin dependent and immunoglobulin independent mechanisms. The Ig-dependent mechanisms may involve the four components of the kidney parenchyma, and the primary structure of these proteins determine the pattern of renal disease. KEY MESSAGE: This review summarizes the existing literature in the pathobiology of multiple myeloma, and the pathological properties of the M-proteins, focusing on the mechanisms of the renal manifestations related to these abnormal proteins, especially glomerular injury. Also it supports the opinion that monoclonal gammopathy of undetermined significance (MGUS) should not be used in cases where there is proven renal impairment due to these proteins, even if it is mild and does not meet the current criteria.
Assuntos
Imunoglobulinas/química , Nefropatias/etiologia , Mieloma Múltiplo/complicações , Humanos , Imunoglobulinas/metabolismo , Rim/metabolismo , Nefropatias/diagnóstico , Nefropatias/metabolismo , Mieloma Múltiplo/diagnóstico , Mieloma Múltiplo/metabolismo , Proteínas do Mieloma/química , Proteínas do Mieloma/metabolismo , Paraproteinemias/complicações , Paraproteinemias/diagnóstico , Paraproteinemias/metabolismoRESUMO
A long-lived metastable minor fraction has been detected and characterized in myeloma protein IgG4 MAM by hydro- and thermodynamic methods. The sedimentation constants of the minor and the major protein fractions are different. The stability of the two CH2 domains in the minor fraction varies. The unique characteristics of these IgG4 MAM conformers arise from the fact that on exchange of the heavy chains between IgG4 molecules, in some of them only one noncanonical bond Cys226-Cys229 is formed in the central part of the "hinge region" instead of two canonical interchain disulfide bonds Cys226-Cys226 and Cys229-Cys229. This leads to asymmetric structure of the IgG4 MAM molecules.
Assuntos
Regiões Constantes de Imunoglobulina/química , Imunoglobulina G/química , Cadeias Pesadas de Imunoglobulinas/química , Proteínas do Mieloma/química , Dissulfetos/química , HumanosAssuntos
Grânulos Citoplasmáticos/ultraestrutura , Mieloma Múltiplo/ultraestrutura , Plasmócitos/ultraestrutura , Corantes Azur , Corantes , Grânulos Citoplasmáticos/enzimologia , Humanos , Cadeias kappa de Imunoglobulina/química , Lisossomos/enzimologia , Lisossomos/ultraestrutura , Proteínas do Mieloma/química , Coloração e Rotulagem , Vacúolos/química , Vacúolos/ultraestruturaRESUMO
BACKGROUND: Characterization of the immunoglobulin gene repertoire has improved our understanding of the immunopathogenesis of lymphoid tumors. Early B-lymphocyte precursors of multiple myeloma are known to exist and might be susceptible to antigenic drive. DESIGN AND METHODS: To verify this hypothesis, we collected a database of 345 fully readable multiple myeloma immunoglobulin sequences. We characterized the immunoglobulin repertoire, analyzed the somatic hypermutation load, and investigated for stereotyped receptor clusters. RESULTS: Compared to the normal immunoglobulin repertoire, multiple myeloma displayed only modest differences involving only a few genes, showing that the myeloma immunoglobulin repertoire is the least skewed among mature B-cell tumors. Median somatic hypermutation load was 7.8%; median length of complementarity determining-region 3 was 15.5 amino acids. Clustering analysis showed the absence of myeloma specific clusters and no similarity with published chronic lymphocytic leukemia or lymphoma subsets. CONCLUSIONS: Analysis of multiple myeloma immunoglobulin repertoire does not support a pathogenetic role for antigen selection in this tumor.
Assuntos
Regiões Determinantes de Complementaridade/genética , Genes de Cadeia Pesada de Imunoglobulina/imunologia , Mieloma Múltiplo/genética , Proteínas do Mieloma/genética , Linfócitos B/imunologia , Linfócitos B/patologia , Regiões Determinantes de Complementaridade/química , Regiões Determinantes de Complementaridade/imunologia , Mineração de Dados , Bases de Dados de Ácidos Nucleicos , Humanos , Família Multigênica/imunologia , Mieloma Múltiplo/imunologia , Proteínas do Mieloma/química , Proteínas do Mieloma/imunologia , Análise de Sequência de DNA , Hipermutação Somática de Imunoglobulina/imunologiaRESUMO
IgA is the most abundantly produced antibody and plays an important role in the mucosal immune system. Human IgA is represented by two isotypes, IgA1 and IgA2. The major structural difference between these two subclasses is the presence of nine potential sites of O-glycosylation in the hinge region between the first and second constant region domains of the heavy chain. Thr(225), Thr(228), Ser(230), Ser(232) and Thr(236) have been identified as the predominant sites of O-glycan attachment. The range and distribution of O-glycan chains at each site within the context of adjacent sites in this clustered region create a complex heterogeneity of surface epitopes that is incompletely defined. We previously described the analysis of IgA1 O-glycan heterogeneity by use of high resolution LC-MS and electron capture dissociation tandem MS to unambiguously localize all amino acid attachment sites in IgA1 (Ale) myeloma protein. Here, we report the identification and elucidation of IgA1 O-glycopeptide structural isomers that occur based on amino acid position of the attached glycans (positional isomers) and the structure of the O-glycan chains at individual sites (glycan isomers). These isomers are present in a model IgA1 (Mce1) myeloma protein and occur naturally in normal human serum IgA1. Variable O-glycan chains attached to Ser(230), Thr(233) or Thr(236) produce the predominant positional isomers, including O-glycans composed of a single GalNAc residue. These findings represent the first definitive identification of structural isomeric IgA1 O-glycoforms, define the single-site heterogeneity for all O-glycan sites in a single sample, and have implications for defining epitopes based on clustered O-glycan variability.
Assuntos
Glicopeptídeos/sangue , Glicopeptídeos/química , Imunoglobulina A/sangue , Imunoglobulina A/química , Sequência de Aminoácidos , Glicopeptídeos/metabolismo , Glicosilação , Humanos , Imunoglobulina A/metabolismo , Isomerismo , Espectrometria de Massas , Modelos Moleculares , Dados de Sequência Molecular , Mieloma Múltiplo , Proteínas do Mieloma/química , Proteínas do Mieloma/metabolismoRESUMO
To investigate the presence of myeloma-associated antigens in Trichinella spiralis and their anti-tumor effect, cross-immune responses between antigens of the myeloma cell SP2/0 versus positive sera to T. spiralis, and antigens of T. spiralis versus positive sera to myeloma cell SP2/0 were determined using T. spiralis and myeloma specific enzyme-linked immunosorbent assays (ELISA). The myeloma-associated antigens in T. spiralis were separated by ultrafiltration and 2-D electrophoresis, and the amino acid sequences and molecular weights were determined by spectrometry. An obvious reaction was found between a 33 kDa antigen and positive sera, and the major component of the antigen was tropomyosin (TM), which is an surface acidic protein with 284 amino acids. Mice were immunized with TM to determine the anti-tumor effect in vivo. The results showed that CD4(+), CD8(+) T lymphocyte, and CD19(+) B lymphocyte were significantly increased (P<0.05). The anti-tumor effects were significantly different between mice immunized with the antigens or adjuvant alone (P<0.05), while the difference between mice immunized with antigens and whole T. spiralis was not significant (P>0.05). The results indicated that TM identified in this study may play a role in eliciting cross-protective immunity.
Assuntos
Antígenos de Helmintos/análise , Antígenos de Neoplasias/análise , Mieloma Múltiplo/imunologia , Proteínas do Mieloma/análise , Trichinella spiralis/imunologia , Sequência de Aminoácidos , Animais , Antígenos de Helmintos/química , Antígenos de Helmintos/imunologia , Antígenos de Neoplasias/química , Antígenos de Neoplasias/imunologia , Western Blotting , Linhagem Celular Tumoral , Reações Cruzadas , Eletroforese em Gel Bidimensional , Ensaio de Imunoadsorção Enzimática , Imuno-Histoquímica , Camundongos , Camundongos Endogâmicos BALB C , Proteínas do Mieloma/química , Proteínas do Mieloma/imunologia , Distribuição Aleatória , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por MatrizAssuntos
Anticorpos Monoclonais/química , Especificidade de Anticorpos , Dineínas/imunologia , Epitopos/imunologia , Imunoglobulina G/química , Mieloma Múltiplo/imunologia , Mieloma Múltiplo/fisiopatologia , Proteínas do Mieloma/química , Anticorpos Monoclonais/isolamento & purificação , Mapeamento de Epitopos , Humanos , Imunoglobulina G/isolamento & purificação , Proteínas do Mieloma/isolamento & purificaçãoAssuntos
Artefatos , Bilirrubina/sangue , Análise Química do Sangue/instrumentação , Colorimetria/instrumentação , Erros de Diagnóstico , Hiperbilirrubinemia/diagnóstico , Cadeias lambda de Imunoglobulina/sangue , Mieloma Múltiplo/sangue , Proteínas do Mieloma/análise , Idoso , Automação , Precipitação Química , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Proteínas do Mieloma/químicaAssuntos
Anticorpos/imunologia , Diversidade de Anticorpos , Proteína de Bence Jones/química , Cadeias Leves de Imunoglobulina/química , Região Variável de Imunoglobulina/química , Imunoglobulinas/química , Proteínas do Mieloma/química , Sequência de Aminoácidos , Animais , Proteína de Bence Jones/imunologia , Regiões Determinantes de Complementaridade/química , Regiões Determinantes de Complementaridade/imunologia , História do Século XX , Humanos , Cadeias Leves de Imunoglobulina/imunologia , Região Variável de Imunoglobulina/imunologia , Imunoglobulinas/imunologia , Camundongos , Mieloma Múltiplo/imunologia , Proteínas do Mieloma/imunologiaRESUMO
IgA is unique in being able to form a diverse range of polymeric structures. Increases in the levels of dimeric IgA1 (dIgA1) in serum have been implicated in diseases such as IgA nephropathy. We have determined the solution structure for dIgA1 by synchrotron x-ray and neutron scattering and analytical ultracentrifugation. The Guinier radius of gyration (RG) of 7.60-8.65 nm indicated that the two monomers within dIgA1 are arranged in an extended conformation. The distance distribution curve P(r) gave an overall length (L) of 22-26 nm. These results were confirmed by the sedimentation coefficient and frictional ratio of dIgA1. Constrained scattering modeling starting from the IgA1 monomer solution structure revealed a near-planar dimer structure for dIgA1. The two Fc regions form a slightly bent arrangement in which they form end-to-end contacts, and the J chain was located at this interface. This structure was refined by optimizing the position of the four Fab regions. From this, the best-fit solution structures show that the four Fab Ag-binding sites are independent of one another, and the two Fc regions are accessible to receptor binding. This arrangement allows dIgA1 to initiate specific immune responses by binding to FcalphaRI receptors, while still retaining Ag-binding ability, and to be selectively transported to mucosal surfaces by binding to the polymeric Ig receptor to form secretory IgA. A mechanism for the involvement of dIgA1 oligomers in the pathology of IgA nephropathy is discussed in the light of this near-planar structure.
Assuntos
Glomerulonefrite por IGA/imunologia , Imunoglobulina A/química , Imunoglobulinas/química , Proteínas do Mieloma/química , Dimerização , Humanos , Imunidade nas Mucosas , Modelos Moleculares , Conformação Proteica , Espalhamento de Radiação , Ultracentrifugação , Raios XRESUMO
IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis. In IgAN, IgA1 molecules with incompletely galactosylated O-linked glycans in the hinge region (HR) are present in mesangial immunodeposits and in circulating immune complexes. It is not known whether the galactose deficiency in IgA1 proteins occurs randomly or preferentially at specific sites. We have previously demonstrated the first direct localization of multiple O-glycosylation sites on a single IgA1 myeloma protein by use of activated ion-electron capture dissociation (AI-ECD) Fourier transform ion cyclotron resonance (FT-ICR) tandem mass spectrometry. Here, we report the analysis of IgA1 O-glycan heterogeneity by use of FT-ICR MS and liquid chromatography FT-ICR MS to obtain unbiased accurate mass profiles of IgA1 HR glycopeptides from three different IgA1 myeloma proteins. Additionally, we report the first AI-ECD fragmentation on an individual IgA1 O-glycopeptide from an IgA1 HR preparation that is reproducible for each IgA1 myeloma protein. These results suggest that future analysis of IgA1 HR from IgAN patients and normal healthy controls should be feasible.
Assuntos
Espectrometria de Massas/métodos , Proteínas do Mieloma/química , Polissacarídeos/análise , Ciclotrons , Análise de Fourier , Glomerulonefrite por IGA , Humanos , Espectrometria de Massas/instrumentaçãoRESUMO
INTRODUCTION: The aim of this study was to differentiate heavy and light chain-derived instability of monoclonal myeloma immunoglobulins by complexation of matched supramolecular dyes. These are composed of several micellar pieces of self-assembled dye molecules which may penetrate the protein interior of the binding locus with polypeptide chains. These dyes were used to elicit, by precipitation, the postulated higher aggregation tendency of the heavy chain derived from its higher hydrophobicity. MATERIALS AND METHODS: Agarose gel electrophoresis was used to create conditions for dye complexation and to reveal the precipitation. RESULTS: Congo red derivatives with aromatic ring substitutes, BACR and DBACR, of increased penetrating capability were chosen to provoke the precipitation of abnormal immunoglobulins by displacing association-prone polypeptide chains from the protein interior. CONCLUSIONS: The results of this study confirm the heavy chain-related propensity of some monoclonal immunoglobulins to aggregate and precipitate. The simplicity of the technique may improve clinical diagnosis and facilitate predictions of disease complications.
Assuntos
Anticorpos Antineoplásicos/química , Corantes/química , Vermelho Congo/análogos & derivados , Cadeias Pesadas de Imunoglobulinas/química , Cadeias Leves de Imunoglobulina/química , Imunoglobulinas/química , Proteínas do Mieloma/química , Coloração e Rotulagem/métodos , Precipitação Química , Vermelho Congo/química , Humanos , Estrutura Molecular , Ligação Proteica , Conformação Proteica , SolubilidadeRESUMO
While investigating 2592 patients enrolled in multicenter myeloma trials, we found light chain-only (LCO) patients had worse median survival times (1.9 years) than patients with IgA and IgG paraproteins (2.3 and 2.5 years, respectively) (P < .001). However, IgA and IgG patients with levels of LC excretion similar to those of LCO patients also had poor survival times because of renal failure, resulting in worse survival during induction therapy and at relapse with no difference in progression-free survival between LCO and IgG patients. LC excretion was higher for lambda than for kappa types, but there was no difference in survival between the 2 LC types when stratified for level of LC excretion, indicating that care of renal function is vital to improving the survival of any patient with LC excretion. LCO patients were younger (P = .001), had worse performance status (P = .001), and had more lytic lesions (P < .001), perhaps reflecting late and missed diagnoses in younger and older LCO patients, respectively. No differences were observed between IgA and IgG patients in presentation characteristics, response, or survival from disease progression. The worse survival of IgA patients was attributed to shorter progression-free survival (median, 1.2 vs 1.6 years; P < .001), which is important for maintenance therapy.